Page last updated: 2024-11-02

phenylbutazone and Cancer of Kidney

phenylbutazone has been researched along with Cancer of Kidney in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
" Uncommon tubular cell tumors of the kidney were found in 13 exposed rats: 5 in the 50 mg group and 4 in the 100 mg group of males; 4 in dosed female rats; none in controls."1.29Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. ( Bucher, J; Eustis, S; Haseman, J; Huff, J; Kari, F, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kari, F1
Bucher, J1
Haseman, J1
Eustis, S1
Huff, J1

Other Studies

1 other study available for phenylbutazone and Cancer of Kidney

ArticleYear
Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:3

    Topics: Adenoma; Animals; Corn Oil; Female; Hyperplasia; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; M

1995